-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Upgrades Moderna to Buy, Announces $180 Price Target

Benzinga·08/28/2026 11:50:59
Listen to the news
Argus Research analyst John Eade upgrades Moderna (NASDAQ:MRNA) from Hold to Buy and announces $180 price target.